MGRX News & Events

Mangoceuticals announced that it has filed a civil lawsuit against Clarity Ventures, its former technology consulting and software development firm. The lawsuit, filed in Texas state court, seeks damages exceeding $73M, exclusive of interest, costs, and attorneys' fees. The company alleges that Clarity failed to deliver a fully functional, HIPAA-compliant enterprise resource planning and e-commerce platform that Clarity had been engaged to design and implement in support of the company's operations. Clarity has denied the company's allegations and has asserted counterclaims related to alleged unpaid invoices. The company believes these counterclaims are unwarranted, as all binding and required payments under the applicable agreements were made in full prior to disengaging from Clarity's services. The company intends to pursue its claims and defend against the counterclaims through the litigation process. Following the events described in the complaint, the company independently developed and deployed a new proprietary telehealth and e-commerce platform designed to support its operations. All allegations remain subject to the litigation process and have not been proven in a court of law.

Mangoceuticals files to sell 2.64M shares of common stock for holders

Mangoceuticals announced an up to $100M Solana-focused digital asset treasury, DAT, strategy in partnership with Cube Group, through its newly formed subsidiary, Mango DAT. This initiative positions Mangoceuticals at the forefront of institutional adoption in the Solana ecosystem, leveraging high-yield opportunities to drive sustainable, non-dilutive growth for shareholders. The Company believes the current crypto market has provided a very strategic opportunity to take advantage of current prices, enabling optimized entry points for long-term value creation.